The Advisory Group on Risk Evidence Education for Dementia: Multidisciplinary and Open to All

Manuscript Number: 

22-0458R1

Author(s): 
Neelum T. Aggarwal, Jalayne J. Arias, J. Wesson Ashford, Deborah Blacker, Jasmeer Chhatwal, Nathaniel A. Chin, Lindsay R. Clark, Sharon S. Denny, Carey E. Gleason, Jill S. Goldman, Joshua D. Grill, Judith L. Heidebrink, Victor W. Henderson, James A. Lavacot, Jennifer H. Lingler, Malavika Menon, Rachel L. Nosheny, Fabricio Ferreira de Oliveira, Annalise M. Rahman-Filipiak, Anwita Revoori, Allyson C. Rosen, Malia Rumbaugh, Danurys L. Sanchez, Suzanne Schindler, Christopher G. Schwartz, Leslie Toy, Jamie Tyrone, Sarah Walter, Li-San Wang, Ellen Wijsman, Monica Willis-Parker, Doris T. Zallen

Disclosures

Neelum T. Aggarwal

  • Nothing to Disclose

Jalayne J. Arias

  • Nothing to Disclose

J. Wesson Ashford

  • Nothing to Disclose

Deborah Blacker

  • Nothing to Disclose

Jasmeer Chhatwal

  • Consulting Fees:
    Otsuka Pharmaceuticals - Medical Advisory Board, <2K

Nathaniel A. Chin

  • Nothing to Disclose

Lindsay R. Clark

  • Nothing to Disclose

Sharon S. Denny

  • Nothing to Disclose

Carey E. Gleason

  • Nothing to Disclose

Jill S. Goldman

  • Nothing to Disclose

Joshua D. Grill

  • Grants
    • Agency: 
      Eli Lilly
      Dates: 
      ongoing
    • Agency: 
      Eisai
      Dates: 
      ongoing
    • Agency: 
      Genentech
      Dates: 
      ongoing
    • Agency: 
      Biogen
      Dates: 
      ongoing

Judith L. Heidebrink

  • Grants
    • Agency: 
      Eisai/Biogen
      Dates: 
      ongoing (trial)
    • Agency: 
      Lilly
      Dates: 
      ongoing (trial)
    • Agency: 
      Biohaven
      Dates: 
      ended 2022 (trial)

Victor W. Henderson

  • Nothing to Disclose

James A. Lavacot

  • Nothing to Disclose

Jennifer H. Lingler

  • Consulting Fees:
    Biogen Intuition Study consultant Genentech advisory board consultant

Malavika Menon

  • Nothing to Disclose

Rachel L. Nosheny

  • Grants
    • Agency: 
      Genentech, Inc.
      Dates: 
      01/01/2021-12/31/2022

Fabricio Ferreira de Oliveira

  • Consulting Fees:
    I receive regular consulting fees from Gerson Lehrman Group (GLG), Atheneum Partners, Guidepoint, and Lionbridge.

Annalise M. Rahman-Filipiak

  • Nothing to Disclose

Anwita Revoori

  • Nothing to Disclose

Allyson C. Rosen

  • Nothing to Disclose

Malia Rumbaugh

  • Nothing to Disclose

Danurys L. Sanchez

  • Nothing to Disclose

Suzanne Schindler

  • Nothing to Disclose

Christopher G. Schwartz

  • Nothing to Disclose

Leslie Toy

  • Nothing to Disclose

Jamie Tyrone

  • Nothing to Disclose

Sarah Walter

  • Nothing to Disclose

Li-San Wang

  • Nothing to Disclose

Ellen Wijsman

  • Nothing to Disclose

Monica Willis-Parker

  • Nothing to Disclose

Doris T. Zallen

  • Nothing to Disclose